Lauren Huff is a writer at Entertainment Weekly with over a decade of experience covering all facets of the entertainment industry. After graduating with honors from the University of Texas at ...

Find out more about how we test. We originally reviewed the Mission 700 back in 2022 and they remain one of the more interesting contenders at the price. These are relatively big boxes, standing a ...

After five years away from the role, Tom Cruise retuned as special agent Ethan Hunt for Mission: Impossible – Dead Reckoning Part One. As Paramount gears up to release The Final Reckoning later ...

And that's just what a spacecraft built and operated by Texas-based Firefly Aerospace has set out to do on its 60-day mission to Earth's only natural satellite. Upon arrival, Firefly's spacecraft ...

To David Hooper, the president of the New Mission Terrace Improvement Association and a retired ... is often said to have put more emphasis on the Excelsior. Safaí, on the other hand, is said to have ...

BARNETT WHITETAIL HUNTER CROSSBOW STR WITHOUT CRANK DEVICE: Ultra-compact compound crossbow with complete hunting accessory package. The lightweight crossbow has a manageable profile that hunters ...

Two months since a Jacksonville woman died after her car broke down on the Mathews Bridge, another suffered a similar fate. Sunday at about 5 a.m. a 39-year-old Jacksonville woman's SUV became ...

London — A 26-year-old man pleaded guilty Wednesday to the murder of a mother and two of her daughters at their family home just north of London last year, in an attack that involved a crossbow ...

With power-disrupting storms set to become a more frequent part of our lives, it makes sense to prepare home back-up systems to cope with the blackouts. Here’s a look at some of the technology ...

In October, Los Angeles Mayor Karen Bass signed Executive Directive #9 to establish a citywide capital infrastructure plan. The directive was at once a breakthrough for L.A. and a demonstration of ...

Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small interfering RNA (siRNA) candidates in epilepsy and Huntington’s disease.